Dr Khadijah A Abdurrazaq, MD, FAAP | |
801 E Florida Ave, Midland, TX 79701-8212 | |
(432) 685-0450 | |
Not Available |
Full Name | Dr Khadijah A Abdurrazaq |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 801 E Florida Ave, Midland, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336304120 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | D0071810 (Maryland) | Secondary |
208000000X | Pediatrics | P4277 (Texas) | Primary |
Entity Name | Midland Community Healthcare Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235225087 PECOS PAC ID: 0345230975 Enrollment ID: O20040515000364 |
News Archive
Substantial progress has been made over the last 15 years in the healthcare community's ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy management has not reached most of the 50 million people around the world, including many of the nearly three million people in the United States who have the disorder.
"The world is facing two immediate health crises concerning drugs and vaccines: affordable and reliable access to life-sparing medicines and the safety and reliability of those medicines," Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), writes in the council's Policy Innovation Memorandum No. 21, titled, "Ensuring the Safety and Integrity of the World's Drug, Vaccine, and Medicines Supply."
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.
In a White House briefing on Wednesday, "senior Administration officials announced a series of new initiatives to promote game-changing innovations to solve long-standing development challenges" in response to President Obama's "call to harness science technology, and innovation to spark global development," Gayle Smith, special assistant to the president, and Tom Kalil, senior adviser for science, technology, and innovation, write in this post in the White House Blog.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Khadijah A Abdurrazaq, MD, FAAP 4411 W Dengar Ave, Midland, TX 79707-5305 Ph: (281) 777-9302 | Dr Khadijah A Abdurrazaq, MD, FAAP 801 E Florida Ave, Midland, TX 79701-8212 Ph: (432) 685-0450 |
News Archive
Substantial progress has been made over the last 15 years in the healthcare community's ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy management has not reached most of the 50 million people around the world, including many of the nearly three million people in the United States who have the disorder.
"The world is facing two immediate health crises concerning drugs and vaccines: affordable and reliable access to life-sparing medicines and the safety and reliability of those medicines," Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), writes in the council's Policy Innovation Memorandum No. 21, titled, "Ensuring the Safety and Integrity of the World's Drug, Vaccine, and Medicines Supply."
Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.
A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil (MMF) to an increased risk of central nervous system (CNS) lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors (CNIs), given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.
In a White House briefing on Wednesday, "senior Administration officials announced a series of new initiatives to promote game-changing innovations to solve long-standing development challenges" in response to President Obama's "call to harness science technology, and innovation to spark global development," Gayle Smith, special assistant to the president, and Tom Kalil, senior adviser for science, technology, and innovation, write in this post in the White House Blog.
› Verified 5 days ago
Mohammed Hussein Nasser Aljarwi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4214 Andrews Hwy Ste 102, Midland, TX 79703 Phone: 432-221-5580 Fax: 432-221-5585 | |
Dr. Wellington F Ballesteros, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2500 Delano Ave, Midland, TX 79701 Phone: 432-697-4747 Fax: 432-699-3813 | |
Nidhi Girishchandra Shah, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4214 Andrews Hwy Ste 310, Midland, TX 79703 Phone: 432-697-4747 Fax: 432-699-3813 | |
Chandan Mazumder, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1900 W Wall St Ste C, Midland, TX 79701 Phone: 432-221-2500 Fax: 432-687-1914 | |
Jennifer Blackerby, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3600 N Garfield St, Midland, TX 79705 Phone: 432-620-1120 | |
Kranthi Nandan Seelaboyina, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 316 Secor St, Midland, TX 79701 Phone: 432-620-1111 Fax: 432-620-1112 | |
Megan Breanne Rossman, PA-C Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 302 Secor St, Midland, TX 79701 Phone: 432-685-5029 |